GCN5 drives MASLD progression through LXRα/SREBP1c signaling pathway–mediated de novo lipogenesis

Journal:

Nature Communications

Published:

2026-02-16

DOI:

10.1038/s41467-026-69736-y

Affiliations:

7

Authors:

17

Go to article

Institutions	Authors	Share
State Key Laboratory of Natural Medicines (SKLNM), CPU, China	10.500000 10.500000	0.62
Drum Tower Hospital, China	2.000000	0.12
Changzhi Medical College, China	2.000000	0.12
Changzhou No.2 People’s Hospital, NJMU, China	1.000000	0.06
The First People's Hospital of Hangzhou, China	0.500000	0.03
Nanjing Medical University (NJMU), China	0.500000	0.03
Tibet University of Tibetan Medicine, China	0.500000	0.03

Interested in Medical Biochemistry and Metabolomics?